These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21262777)

  • 1. Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin.
    Ihnen M; Kilic E; Köhler N; Löning T; Witzel I; Hagel C; Höller S; Kersten JF; Müller V; Jänicke F; Milde-Langosch K
    J Clin Pathol; 2011 Feb; 64(2):146-52. PubMed ID: 21262777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
    Tachezy M; Zander H; Marx AH; Gebauer F; Rawnaq T; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
    J Surg Res; 2011 Oct; 170(2):226-32. PubMed ID: 21816425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
    Davies S; Jiang WG
    Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
    Ihnen M; Müller V; Wirtz RM; Schröder C; Krenkel S; Witzel I; Lisboa BW; Jänicke F; Milde-Langosch K
    Breast Cancer Res Treat; 2008 Dec; 112(3):419-27. PubMed ID: 18172759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
    Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
    J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.
    Ihnen M; Köhler N; Kersten JF; Milde-Langosch K; Beck K; Höller S; Müller V; Witzel I; Jänicke F; Kilic E
    Dis Markers; 2010; 28(2):71-8. PubMed ID: 20364042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated Leukocyte Cell Adhesion Molecule (ALCAM) is associated with suppression of breast cancer cells invasion.
    Jezierska A; Olszewski WP; Pietruszkiewicz J; Olszewski W; Matysiak W; Motyl T
    Med Sci Monit; 2006 Jul; 12(7):BR245-56. PubMed ID: 16810131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells.
    Iwabuchi E; Miki Y; Onodera Y; Shibahara Y; Takagi K; Suzuki T; Ishida T; Sasano H
    Clin Exp Metastasis; 2019 Oct; 36(5):423-432. PubMed ID: 31222613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
    Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of skeletal metastases.
    Kitazawa S; Maeda S
    Clin Orthop Relat Res; 1995 Mar; (312):45-50. PubMed ID: 7634617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers.
    Tsang JY; Kwok YK; Chan KW; Ni YB; Chow WN; Lau KF; Shao MM; Chan SK; Tan PH; Tse GM
    Breast Cancer Res Treat; 2013 Nov; 142(2):311-22. PubMed ID: 24186057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).
    Clauditz TS; von Rheinbaben K; Lebok P; Minner S; Tachezy M; Borgmann K; Knecht R; Sauter G; Wilczak W; Blessmann M; Münscher A
    Pathol Res Pract; 2014 Oct; 210(10):649-55. PubMed ID: 25028217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
    Jezierska A; Matysiak W; Motyl T
    Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.
    Ferragut F; Cagnoni AJ; Colombo LL; Sánchez Terrero C; Wolfenstein-Todel C; Troncoso MF; Vanzulli SI; Rabinovich GA; Mariño KV; Elola MT
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1338-1352. PubMed ID: 30905597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of carcinoembryonic antigen cell adhesion molecule 6 oncoprotein in atypical ductal hyperplastic tissues is associated with the development of invasive breast cancer.
    Poola I; Shokrani B; Bhatnagar R; DeWitty RL; Yue Q; Bonney G
    Clin Cancer Res; 2006 Aug; 12(15):4773-83. PubMed ID: 16899629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells.
    Fernández MM; Ferragut F; Cárdenas Delgado VM; Bracalente C; Bravo AI; Cagnoni AJ; Nuñez M; Morosi LG; Quinta HR; Espelt MV; Troncoso MF; Wolfenstein-Todel C; Mariño KV; Malchiodi EL; Rabinovich GA; Elola MT
    Biochim Biophys Acta; 2016 Oct; 1860(10):2255-68. PubMed ID: 27130882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation.
    Penna E; Orso F; Cimino D; Vercellino I; Grassi E; Quaglino E; Turco E; Taverna D
    Cancer Res; 2013 Jul; 73(13):4098-111. PubMed ID: 23667173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients.
    Burandt E; Bari Noubar T; Lebeau A; Minner S; Burdelski C; Jänicke F; Müller V; Terracciano L; Simon R; Sauter G; Wilczak W; Lebok P
    Oncol Rep; 2014 Dec; 32(6):2628-34. PubMed ID: 25270339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.
    Sihto H; Lundin J; Lundin M; Lehtimäki T; Ristimäki A; Holli K; Sailas L; Kataja V; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Breast Cancer Res; 2011 Sep; 13(5):R87. PubMed ID: 21914172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.